CSF2RB and Crohn disease: In support of this, a genetic analysis of Ashkenazi Jewish populations, which show a high prevalence of Crohn’s disease, demonstrates that monocytes from carriers of a frameshift mutation in CSF2RB gene exhibit reduced responses to GM-CSF treatment (Chuang et al., 2016).